IBM’s AI can predict how Parkinson’s disease can progress in individuals


In the past, we have seen doctors use AI detection software brain tumors,, kidney disease and various carcinomas. Now researchers from IBM and the Michael J. Fox Foundation (MJFF) say they have developed a program that can predict how the symptoms of a Parkinson’s patient will progress in terms of both time and severity. U Lancet Digital Health Journal, they argue that the software could transform the way doctors help patients manage their symptoms, allowing them to better predict how the disease will progress.

“Our goal is to use AI to help manage patients and design clinical trials. “These goals are important because, despite Parkinson’s prevalence, patients have a unique variety of motor and non-motor symptoms,” said IBM.

The breakthrough would not have been possible without Parkinson’s initiative to mark progression, a study sponsored by the Michael J. Fox Foundation. IBM describes the dataset, which includes information on more than 1,400 individuals, as “the largest and best volume of longitudinal Parkinson’s patient data to date” and says it allowed its AI model to map complex patterns of symptoms and progression.

Parkinson’s disease is estimated to affect more than 6 million people globally, and there is currently no known cure for it. IBM Research and MJFF plan to continue working on the AI ​​model. In the future, they hope to improve it by providing more detailed characteristics of different stages of the disease.

All products recommended by Engadget are selected by our editorial team, regardless of our parent company. Some of our stories include associated links. If you buy something through one of these links, we may earn an associated commission.

Source link


Please enter your comment!
Please enter your name here